Abdominal aortic aneurysm, without rupture
Methodology & AI Transparency ⓘ
Abdominal aortic aneurysm, without rupture Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code I71.40 in Blood Pressure, Abdominal aortic aneurysm, without rupture requires vascular stiffness assessment [Abdominal aortic aneurysm, without rupture I71.40] so specialists can calibrate treatment intensity against Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] benchmarks.
- 2 Real-world patient consensus: Clinical coding for Abdominal aortic aneurysm, without rupture uses ICD-10 I71.40 across Blood Pressure specialty care.
- 3 Typical cash cost range: Workup highlights for Abdominal aortic aneurysm, without rupture (I71.40): vascular stiffness assessment [Abdominal aortic aneurysm, without rupture I71.40].
- 4 Top reported side effects / signs: Follow-up benchmark in Abdominal aortic aneurysm, without rupture: maintaining Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] within < 15 mg/g (I71.40).
Ask our AI Specialists anything about Abdominal aortic aneurysm, without rupture
What Is Abdominal aortic aneurysm, without rupture?
Cataloged under federal diagnostic code I71.40 in Blood Pressure, Abdominal aortic aneurysm, without rupture requires vascular stiffness assessment [Abdominal aortic aneurysm, without rupture I71.40] so specialists can calibrate treatment intensity against Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Abdominal aortic aneurysm, without rupture (code I71.40) is intimal-medial vascular remodeling [Abdominal aortic aneurysm, without rupture I71.40], which High Blood Pressure & Vascular Health clinicians address while surveilling Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] (< 15 mg/g (I71.40)).
Common Symptoms & Clinical Signs
- • Presentation of Abdominal aortic aneurysm, without rupture (I71.40): morning occipital headache, in Abdominal aortic aneurysm, without rupture (I71.40: pulsatile tinnitus, or)
- • Secondary Abdominal aortic aneurysm, without rupture clinical sign: calf cramping or in Abdominal aortic aneurysm, without rupture (I71.40: claudication triggered by)
- • Symptom flares in Abdominal aortic aneurysm, without rupture correlating with Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] deviation outside < 15 mg/g (I71.40)
- • Functional blood pressure impact requiring vascular stiffness assessment [Abdominal aortic aneurysm, without rupture I71.40] evaluation (I71.40)
Abdominal aortic aneurysm, without rupture Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I71.40 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Abdominal aortic aneurysm, without rupture I71.40] | < 15 mg/g (I71.40) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Abdominal aortic aneurysm, without rupture (I71.40: Pressure) | < 120/75 mmHg (I71.40) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Abdominal aortic aneurysm, without rupture I71.40] | 1.00 – 1.30 (I71.40) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Abdominal aortic aneurysm, without rupture
Treatment selection for Abdominal aortic aneurysm, without rupture depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Abdominal aortic aneurysm, without rupture)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete: What a 1,382-Participant Study Found Tenapanor was observed to improve abdominal symptoms independent of its effect on bowel symptoms in adults with IBS-C. Digestive diseases (Basel, Switzerland) • 2025-01-15 • Phase III Randomized Trial | N = 1,382 | 96/100 | PMID 39701047 ↗ |
| New Insights on Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel: What a 1,436-Participant Study Found Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating. Digestive diseases and sciences • 2024-05-15 • Phase III Randomized Trial | N = 1,436 | 96/100 | PMID 38594429 ↗ |
| New Insights on Tegileridine for moderate-to-severe acute pain following abdominal surgery: A: What a 526-Participant Study Found The total pain relief scores (mean [SD]) at 24 h were 58.76 (21.79) with 0.75 mg tegileridine and 61.95 (18.94) with 1.0 mg tegileridine, compared with 47.56 (21.00) with placebo and 59.09 (19.34) with morphine. Cell reports. Medicine • 2025-12-16 • Phase III Randomized Trial | N = 526 | 93/100 | PMID 41365300 ↗ |
| New Insights on Sustained blood-pressure-lowering activity of telmisartan compared with: What a 447-Participant Study Found Due to its longer half-life, telmisartan offers more sustained BP control, especially at the end of the dosing period and provides sustained efficacy in poorly compliant patients in the event of a missed dose with a... Blood pressure monitoring • 2004-08-15 • Randomized Controlled Trial | N = 447 | 93/100 | PMID 15311147 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase III, multicenter, gold-standard blind, randomized clinical trial to In Chinese adult participants with cIAI, C/T plus metronidazole was noninferior to meropenem, with comparable safety. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases • 2022-10-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35987467 ↗ |
Abdominal aortic aneurysm, without rupture Patient Community & “People Like Me” Threads
Filter Abdominal aortic aneurysm, without rupture community threads and patient logs by age, biological sex, dosage, and treatment duration.